Quantcast

Latest Dana-Farber Cancer Institute Stories

2012-03-27 05:17:46

Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin.

2012-03-22 22:34:14

Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.

2012-03-22 22:32:59

Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin.

2012-03-15 12:00:00

South Korea’s largest hospital to offer dynamic digital publication for the international medical traveler Chapel Hill, NC (PRWEB) March 15, 2012

2012-02-14 15:28:52

Scientists at Dana-Farber Cancer Institute have identified a subtype of ovarian cancer able to build its own blood vessels, suggesting that such tumors might be especially susceptible to "anti-angiogenic" drugs that block blood vessel formation.

2012-02-09 15:04:19

The vast majority of patients with incurable lung or colorectal cancer talk with a physician about their options for care at the end of life, but often not until late in the course of their illness.

2012-02-07 12:08:41

Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects.


Word of the Day
bowerly
  • Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.